Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk

The frequency of cells with structural chromosomal aberrations (CAs) in peripheral blood lymphocytes is the first genotoxicity biomarker that has shown an association with cancer risk. CAs are usually divided into chromosome-type (CSAs) and chromatid-type aberrations (CTAs), with different mechanisms of formation. From a mechanistic point of view, it is of interest to clarify whether the cancer predictivity of CAs is different with respect to CSAs and CTAs. We report here cancer risk for cytogenetically tested, healthy subjects with respect to frequency of CAs, CSAs, and CTAs in peripheral blood lymphocytes, using Nordic (1981 subjects with CA data, 1871 subjects with CSA/CTA data) and Italian (1573 subjects with CA data, 877 subjects with CTA/CSA data) cohorts, with a median follow-up of 17 years. High levels of CAs at test were clearly associated with increased total cancer incidence in the Nordic cohorts and increased total cancer mortality in the Italian cohort. In the Nordic cohorts, significantly elevated cancer risks were observed for subjects with both high CSAs and high CTAs at test, and these variables showed equally strong cancer predictivity. The results of the Italian cohort did not indicate any clear-cut difference in cancer predictivity between the CSA and CTA biomarkers. There was no significant effect modification by age at test, gender, country, or time since test. The results suggest that both DNA double-strand breaks and other initial DNA lesions responsible for CSAs and CTAs are associated with cancer risk.

[1]  E. Mark,et al.  Polymorphisms in the Dna Repair Genes Xrcc1 and Ercc2 and Biomarkers of Dna Damage in Human Blood Mononuclear Cells Cross-complementing Group 1) than in 399arg/arg Carriers of Breaks following Base Excision Repair (ber) Resulting From , 2022 .

[2]  M. Brabec,et al.  Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. , 2000, Environmental health perspectives.

[3]  Jack A. Taylor,et al.  DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  Sikandar G. Khan,et al.  An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. , 2001, Cancer research.

[5]  B. Morris,et al.  hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  H. Norppa.  Cytogenetic biomarkers. , 2004, IARC scientific publications.

[7]  J. Lamerdin,et al.  Rare microsatellite polymorphisms in the DNA repair genesXRCC1, XRCC3 andXRCC5 associated with cancer in patients of varying radiosensitivity , 1997, Somatic cell and molecular genetics.

[8]  S. Masetti,et al.  Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease , 2003, Human Genetics.

[9]  A. Brøgger,et al.  Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. , 1994, Cancer research.

[10]  W. Au,et al.  Interactions between genetic predisposition and environmental toxicants for development of lung cancer , 1997, Environmental and molecular mutagenesis.

[11]  D. Tang,et al.  DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. , 2002, Carcinogenesis.

[12]  G. Falck,et al.  Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. , 1997, Mutation research.

[13]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.

[14]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.

[15]  W. Goedecke,et al.  Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. , 2000, Mutagenesis.

[16]  G. Morgan,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Brabec,et al.  Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations. , 2002, Mutation research.

[18]  H. Norppa.  Genetic polymorphisms and chromosome damage. , 2001, International journal of hygiene and environmental health.

[19]  C. H. Kim,et al.  Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  A. Hirvonen.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. , 1999, Environmental health perspectives.

[21]  J. Yokota,et al.  Infrequent Mutations of the hOGG1 Gene, That Is Involved in the Excision of 8‐Hydroxyguanine in Damaged DNA, in Human Gastric Cancer , 1998, Japanese journal of cancer research : Gann.

[22]  G. Morgan,et al.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.

[23]  U. Vogel,et al.  Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  M. Spitz,et al.  From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. , 2003, DNA repair.

[25]  L. Hsieh,et al.  XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers , 2003, Archives of Toxicology.

[26]  J. Park,et al.  Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. , 2003, Carcinogenesis.

[27]  F. Gilliland,et al.  The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. , 2001, Mutation research.

[28]  A. Harris,et al.  A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. , 2000, Cancer research.

[29]  P. S. Nielsen,et al.  Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  H. Norppa,et al.  Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. , 2000, Cancer research.

[31]  E. Holly,et al.  A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. , 2002, Cancer research.

[32]  M. Tockman,et al.  Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  J. Luo,et al.  Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. , 2002, Mutation research.

[34]  M D Waters,et al.  IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. , 2000, Mutation research.

[35]  J. Zwischenberger,et al.  Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. , 2003, Cancer genetics and cytogenetics.

[36]  Chien-Jen Chen,et al.  Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. , 2003, Journal of the National Cancer Institute.

[37]  T. Brüning,et al.  Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. , 2003, International journal of hygiene and environmental health.

[38]  P. Vineis.  Metabolic Polymorphisms and Susceptibility to Cancer , 1999 .

[39]  R. Anzion,et al.  BIOMarkers for occupational diesel exhaust exposure monitoring (BIOMODEM)--a study in underground mining. , 2002, Toxicology letters.

[40]  E J Duell,et al.  Polymorphisms in the DNA repair gene XRCC1 and breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  H. Norppa,et al.  Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). , 1998, Cancer research.

[42]  A. Zijno,et al.  Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. , 2003, Carcinogenesis.

[43]  H. Norppa,et al.  Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. , 2002, Carcinogenesis.

[44]  D. Christiani,et al.  Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. , 2002, Cancer research.

[45]  S. Z. Abdel‐Rahman,et al.  The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. , 2000, Cancer letters.

[46]  M. Spitz,et al.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. , 1999, Carcinogenesis.

[47]  H. Norppa,et al.  575 Genetic polymorphisms of DNA repair and biotransformation genes and possible links with chromosomal aberrations and single-strand breaks in DNA , 2003 .

[48]  B. Levin,et al.  Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. , 2000, Cancer letters.

[49]  S. Bonassi,et al.  Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. , 1995, Cancer genetics and cytogenetics.

[50]  P. Vineis.  The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. , 2002, Toxicology.

[51]  H. Norppa.  Genetic susceptibility, biomarker respones, and cancer. , 2003, Mutation research.

[52]  H. Norppa,et al.  Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. , 2003, Carcinogenesis.

[53]  C. J. Chen,et al.  Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. , 1999, Cancer research.

[54]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  S. Garte,et al.  Metabolic susceptibility genes as cancer risk factors: time for a reassessment? , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  D. Hunter,et al.  MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. , 1999, The Journal of nutrition.

[57]  A. Brøgger,et al.  An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. , 1990, Cancer genetics and cytogenetics.

[58]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[59]  Diana Anderson,et al.  Human monitoring after environmental and occupational exposure to chemical and physical agents/ edited by Diana Anderson, Ali Esat Karakaya, and Radim J. Šrám , 2000 .

[60]  A. Hirvonen.  Polymorphic NATs and cancer predisposition. , 1999, IARC scientific publications.